Telsey Advisory Group Has Negative View of ACI Q3 Earnings

Albertsons Companies, Inc. (NYSE:ACI) – Analysts at Telsey Advisory Group dropped their Q3 2025 earnings per share estimates for Albertsons Companies in a report released on Tuesday, October 15th. Telsey Advisory Group analyst J. Feldman now anticipates that the company will post earnings per share of $0.59 for the quarter, down from their prior estimate of $0.69. Telsey Advisory Group currently has a “Market Perform” rating and a $27.25 target price on the stock. The consensus estimate for Albertsons Companies’ current full-year earnings is $2.25 per share. Telsey Advisory Group also issued estimates for Albertsons Companies’ FY2025 earnings at $2.03 EPS.

Albertsons Companies (NYSE:ACI) last issued its quarterly earnings data on Tuesday, October 15th. The company reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.03. Albertsons Companies had a net margin of 1.41% and a return on equity of 56.01%. The business had revenue of $18.55 billion during the quarter, compared to analysts’ expectations of $18.47 billion. During the same quarter in the previous year, the company earned $0.60 EPS. The business’s revenue was up 1.4% on a year-over-year basis.

A number of other equities analysts have also commented on the company. Melius Research started coverage on Albertsons Companies in a research note on Monday, September 23rd. They set a “hold” rating and a $19.00 price objective on the stock. BMO Capital Markets decreased their price target on Albertsons Companies from $21.00 to $19.00 and set a “market perform” rating on the stock in a research report on Wednesday. Four analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $22.89.

Albertsons Companies Stock Up 0.7 %

NYSE ACI opened at $18.43 on Thursday. The company has a current ratio of 0.88, a quick ratio of 0.21 and a debt-to-equity ratio of 2.67. The company has a market cap of $10.67 billion, a price-to-earnings ratio of 8.26, a PEG ratio of 1.02 and a beta of 0.48. The company has a 50 day moving average of $19.14 and a 200-day moving average of $19.85. Albertsons Companies has a 1-year low of $17.80 and a 1-year high of $23.47.

Albertsons Companies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 8th. Investors of record on Monday, October 28th will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Monday, October 28th. This represents a $0.48 annualized dividend and a dividend yield of 2.60%. Albertsons Companies’s dividend payout ratio is currently 21.52%.

Institutional Trading of Albertsons Companies

Several large investors have recently bought and sold shares of the business. Geneos Wealth Management Inc. bought a new position in shares of Albertsons Companies in the first quarter worth about $41,000. Signaturefd LLC lifted its stake in Albertsons Companies by 108.4% in the 2nd quarter. Signaturefd LLC now owns 2,365 shares of the company’s stock valued at $47,000 after purchasing an additional 1,230 shares during the last quarter. Blue Trust Inc. boosted its position in Albertsons Companies by 2,948.4% in the second quarter. Blue Trust Inc. now owns 2,896 shares of the company’s stock valued at $62,000 after buying an additional 2,801 shares in the last quarter. UniSuper Management Pty Ltd grew its stake in shares of Albertsons Companies by 133.3% during the first quarter. UniSuper Management Pty Ltd now owns 4,900 shares of the company’s stock worth $105,000 after buying an additional 2,800 shares during the last quarter. Finally, Intact Investment Management Inc. acquired a new position in shares of Albertsons Companies during the second quarter worth $126,000. 71.35% of the stock is owned by institutional investors and hedge funds.

Albertsons Companies Company Profile

Albertsons Companies, Inc, through its subsidiaries, engages in the operation of food and drug stores in the United States. The company’s food and drug retail stores offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel, and other items and services. It also manufactures and processes food products for sale in stores.